ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Aeon Biopharma (AEON)
Aeon Biopharma stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · NYSE
$0.24▲ +0.13%
Prices as of Oct 26, 2026 · USD
Chance of rising in 1 month
44%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Aeon Biopharma in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Aeon Biopharma
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Aeon Biopharma a 44% chance of finishing higher a month from now (21 trading sessions) than today: somewhat worse than a coin flip.
In half of the simulated outcomes the price ends between $0.20 and $0.27; in 9 out of 10, between $0.14 and $0.37. Estimated annual volatility is 98%.
Price, last 12 months (weekly close)
Key numbers
- 52-week high
- $1.45
- 52-week low
- $0.18
- Revenue (12 months)
- $0.0M
- Earnings growth (YoY)
- -105.4%
- Return on equity
- 71.3%
- Free cash flow (12 months)
- $-7.2M
- Beta
- 0.65
What this means
ATLAS does not publish a fair value for AEON right now, but it does show its odds of rising: somewhat worse than a coin flip.
Over the last 52 weeks AEON has traded between $0.18 and $1.45. Today it is 83.4% below that high and 33% above its low.
Its beta is 0.65: it tends to move less than the market.
About the company
Aeon Biopharma, Inc. Class A Common Stock represents the equity of Aeon Biopharma, Inc., a biopharmaceutical company focused on developing botulinum toxin-based therapies for therapeutic use.
Want to see everything about Aeon Biopharma?
Get started →Plans from €3.99 a month.
Frequently asked questions
What does Aeon Biopharma do?
Aeon Biopharma, Inc. Class A Common Stock represents the equity of Aeon Biopharma, Inc., a biopharmaceutical company focused on developing botulinum toxin-based therapies for therapeutic use.
What is the chance AEON goes up next month?
44%: somewhat worse than a coin flip. In half of the simulated outcomes, AEON ends the month between $0.20 and $0.27.
How volatile is AEON?
ATLAS estimates annual volatility at 98%. In a typical month, half of the outcomes end between $0.20 and $0.27.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer